Geoffrey Maltzahn - Profile and Investment Details

Investor Profile

Geoffrey Maltzahn is a Venture Capital, Entrepreneurship Program, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods, Inzen Therapeutics, Ohana Biosciences, T2 Biosystems, Tangent Medical Technologies, Kaleido BioSciences, Permeon Biologics, Kovio, Oasys Water, Editas Medicine, Tessera Therapeutics, Generate Biomedicines, Inc., Ring Therapeutics, Moderna Therapeutics, Omega Therapeutics, Cygnal Therapeutics, Sana Biotechnology, Seres Therapeutics, Agios Pharmaceuticals, Red Rock Biofuels, Tarveda Therapeutics, Receptos, Repertoire Immune Medicines, Generate Biomedicines, Codiak Biosciences, BlackDuck, Polatis, Seventh Sense Biosystems, Sigilon Therapeutics, Boragen, TARIS Biomedical, TransMedicsSelecta Biosciences, Quanterix, Visterra, Cobalt Biomedicine, Inc., Sesen Bio, Inc., CiBO Technologies, medidametrics, Rubius Therapeutics, Axcella, Senda Biosciences, Foghorn Therapeutics, Evelo Biosciences, Inari, Joule Unlimited Technologies, Cellarity, WikiCell Designs, Avedro, Indigo, EcoSense Lighting, Valo Health, Invaio Sciences, Sana Biotechnology, Inc., . Over time, Geoffrey Maltzahn has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Geoffrey Maltzahn is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Drug Discovery, Wellness, Women Founded, Enterprise Software, Energy, Life Science, Engineering, Artificial Intelligence (AI), Robotics, Cloud Computing, Technology, Synthetic Biology, Automation, Manufacturing, Biotechnology, Materials Science, Hispanic / Latinx Founded, Clean Technology, Market Research, Data Visualization, Electronic Health Records (EHR), Health and Hospital Services, Groceries, Digital Transformation, Research, Consumer Software, Data Privacy, Agriculture, Utilities, Health Diagnostics, Social Impact, Innovation Management, Generative Tech/AI, Regulatory Compliance, Oil and Gas, Medical, Big Data, Environmental Science, Information Technology, B2B, Therapeutics, Media and Entertainment, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Geoffrey Maltzahn, as their portfolio suggests a familiarity and interest in this area.

Understanding Geoffrey Maltzahn’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.